• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

金银花通过网络药理学分析靶向治疗轻度 COVID-19 的新方法。

New Approach for Targeted Treatment of Mild COVID-19 by Honeysuckle through Network Pharmacology Analysis.

机构信息

Department of Pharmacy, The People's Hospital of Guangxi Zhuang Autonomous Region, Guangxi, China.

Institute of Green Algae, Longhua Branch, Shenzhen People's Hospital, The Second Clinical Medical College of Jinan University, Shenzhen, 518120 Guangdong, China.

出版信息

Comput Math Methods Med. 2022 Feb 21;2022:9604456. doi: 10.1155/2022/9604456. eCollection 2022.

DOI:10.1155/2022/9604456
PMID:35237344
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8885207/
Abstract

OBJECTIVE

To investigate the potential pharmacological value of extracts from honeysuckle on patients with mild coronavirus disease 2019 (COVID-19) infection.

METHODS

The active components and targets of honeysuckle were screened by Traditional Chinese Medicine Database and Analysis Platform (TCMSP). SwissADME and pkCSM databases predict pharmacokinetics of ingredients. The Gene Expression Omnibus (GEO) database collected transcriptome data for mild COVID-19. Data quality control, differentially expressed gene (DEG) identification, enrichment analysis, and correlation analysis were implemented by R toolkit. CIBERSORT evaluated the infiltration of 22 immune cells.

RESULTS

The seven active ingredients of honeysuckle had good oral absorption and medicinal properties. Both the active ingredient targets of honeysuckle and differentially expressed genes of mild COVID-19 were significantly enriched in immune signaling pathways. There were five overlapping immunosignature genes, among which RELA and MAP3K7 expressions were statistically significant ( < 0.05). Finally, immune cell infiltration and correlation analysis showed that RELA, MAP3K7, and natural killer (NK) cell are with highly positive correlation and highly negatively correlated with hematopoietic stem cells.

CONCLUSION

Our analysis suggested that honeysuckle extract had a safe and effective protective effect against mild COVID-19 by regulating a complex molecular network. The main mechanism was related to the proportion of infiltration between NK cells and hematopoietic stem cells.

摘要

目的

研究金银花提取物对轻度 2019 年冠状病毒病(COVID-19)感染患者的潜在药理价值。

方法

通过中药数据库与分析平台(TCMSP)筛选金银花的活性成分和靶点。SwissADME 和 pkCSM 数据库预测成分的药代动力学。基因表达综合数据库(GEO)收集轻度 COVID-19 的转录组数据。通过 R 工具包进行数据质量控制、差异表达基因(DEG)鉴定、富集分析和相关性分析。CIBERSORT 评估 22 种免疫细胞的浸润。

结果

金银花的七种活性成分具有良好的口服吸收性和药效。金银花的活性成分靶点和轻度 COVID-19 的差异表达基因均显著富集于免疫信号通路。有五个重叠的免疫特征基因,其中 RELA 和 MAP3K7 的表达具有统计学意义(<0.05)。最后,免疫细胞浸润和相关性分析表明,RELA、MAP3K7 和自然杀伤(NK)细胞与造血干细胞之间具有高度正相关和高度负相关。

结论

我们的分析表明,金银花提取物通过调节复杂的分子网络对轻度 COVID-19 具有安全有效的保护作用。主要机制与 NK 细胞和造血干细胞之间的浸润比例有关。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e889/8885207/8f43dbc1878a/CMMM2022-9604456.008.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e889/8885207/7d82c07f8c91/CMMM2022-9604456.001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e889/8885207/3e114d349acf/CMMM2022-9604456.002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e889/8885207/6e6012fb3828/CMMM2022-9604456.003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e889/8885207/ecda92fdf93c/CMMM2022-9604456.004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e889/8885207/b1889faeda02/CMMM2022-9604456.005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e889/8885207/bf3e7d7acf62/CMMM2022-9604456.006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e889/8885207/d6d88dc1cbf3/CMMM2022-9604456.007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e889/8885207/8f43dbc1878a/CMMM2022-9604456.008.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e889/8885207/7d82c07f8c91/CMMM2022-9604456.001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e889/8885207/3e114d349acf/CMMM2022-9604456.002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e889/8885207/6e6012fb3828/CMMM2022-9604456.003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e889/8885207/ecda92fdf93c/CMMM2022-9604456.004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e889/8885207/b1889faeda02/CMMM2022-9604456.005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e889/8885207/bf3e7d7acf62/CMMM2022-9604456.006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e889/8885207/d6d88dc1cbf3/CMMM2022-9604456.007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e889/8885207/8f43dbc1878a/CMMM2022-9604456.008.jpg

相似文献

1
New Approach for Targeted Treatment of Mild COVID-19 by Honeysuckle through Network Pharmacology Analysis.金银花通过网络药理学分析靶向治疗轻度 COVID-19 的新方法。
Comput Math Methods Med. 2022 Feb 21;2022:9604456. doi: 10.1155/2022/9604456. eCollection 2022.
2
In silico analysis of the potential mechanism of a preventive Chinese medicine formula on coronavirus disease 2019.基于计算机分析的预防性中药方剂防治 2019 冠状病毒病的潜在作用机制
J Ethnopharmacol. 2021 Jul 15;275:114098. doi: 10.1016/j.jep.2021.114098. Epub 2021 Apr 5.
3
Potential effect of Maxing Shigan decoction against coronavirus disease 2019 (COVID-19) revealed by network pharmacology and experimental verification.网络药理学与实验验证揭示麻杏石甘汤防治 2019 年冠状病毒病(COVID-19)的潜在作用。
J Ethnopharmacol. 2021 May 10;271:113854. doi: 10.1016/j.jep.2021.113854. Epub 2021 Jan 26.
4
Chemical composition and pharmacological mechanism of shenfu decoction in the treatment of novel coronavirus (COVID-19).参附汤治疗新型冠状病毒(COVID-19)的化学成分和药理机制。
Drug Dev Ind Pharm. 2020 Dec;46(12):1947-1959. doi: 10.1080/03639045.2020.1826510. Epub 2020 Oct 19.
5
Based on network pharmacology and bioinformatics to analyze the mechanism of action of Astragalus membranaceus in the treatment of vitiligo and COVID-19.基于网络药理学和生物信息学分析黄芪治疗白癜风和 COVID-19 的作用机制。
Sci Rep. 2023 Mar 8;13(1):3884. doi: 10.1038/s41598-023-29207-6.
6
Investigating the mechanism of ShuFeng JieDu capsule for the treatment of novel Coronavirus pneumonia (COVID-19) based on network pharmacology.基于网络药理学探讨疏风解毒胶囊治疗新型冠状病毒肺炎(COVID-19)的作用机制。
Int J Med Sci. 2020 Sep 12;17(16):2511-2530. doi: 10.7150/ijms.46378. eCollection 2020.
7
A Network Pharmacology Study to Uncover the Multiple Molecular Mechanism of the Chinese Patent Medicine Toujiequwen Granules in the Treatment of Corona Virus Disease 2019 (COVID-19).一项网络药理学研究,旨在揭示中成药透解祛瘟颗粒治疗新型冠状病毒肺炎(COVID-19)的多重分子机制
Curr Med Sci. 2021 Apr;41(2):297-305. doi: 10.1007/s11596-021-2346-x. Epub 2021 Apr 20.
8
Traditional Chinese medicine network pharmacology study on exploring the mechanism of Xuebijing Injection in the treatment of coronavirus disease 2019.基于网络药理学探讨血必净注射液治疗新型冠状病毒肺炎机制的中药研究
Chin J Nat Med. 2020 Dec;18(12):941-951. doi: 10.1016/S1875-5364(20)60038-3.
9
Network pharmacology suggests biochemical rationale for treating COVID-19 symptoms with a Traditional Chinese Medicine.网络药理学为用中药治疗 COVID-19 症状提供了生化原理。
Commun Biol. 2020 Aug 18;3(1):466. doi: 10.1038/s42003-020-01190-y.
10
Bioactive Components of Thunb and Their Potential Mechanisms Against COVID-19 Using Network Pharmacology and Molecular Docking Approaches.《基于网络药理学和分子对接方法探讨菝葜的生物活性成分及其抗 COVID-19 的潜在机制》
J Med Food. 2022 Apr;25(4):355-366. doi: 10.1089/jmf.2021.K.0144.

引用本文的文献

1
Retracted: New Approach for Targeted Treatment of Mild COVID-19 by Honeysuckle through Network Pharmacology Analysis.撤回:金银花通过网络药理学分析靶向治疗轻度新冠肺炎的新方法。
Comput Math Methods Med. 2023 Dec 6;2023:9828416. doi: 10.1155/2023/9828416. eCollection 2023.

本文引用的文献

1
Profound Treg perturbations correlate with COVID-19 severity.严重的 Treg 紊乱与 COVID-19 严重程度相关。
Proc Natl Acad Sci U S A. 2021 Sep 14;118(37). doi: 10.1073/pnas.2111315118.
2
P2Y14 Receptor as a Target for Neutrophilia Attenuation in Severe COVID-19 Cases: From Hematopoietic Stem Cell Recruitment and Chemotaxis to Thrombo-inflammation.P2Y14 受体作为严重 COVID-19 病例中性粒细胞减少的靶点:从造血干细胞募集和趋化作用到血栓炎症。
Stem Cell Rev Rep. 2021 Feb;17(1):241-252. doi: 10.1007/s12015-021-10129-7. Epub 2021 Feb 11.
3
Controlling Cytokine Storm Is Vital in COVID-19.
控制细胞因子风暴是防治 COVID-19 的关键。
Front Immunol. 2020 Nov 30;11:570993. doi: 10.3389/fimmu.2020.570993. eCollection 2020.
4
Harnessing Memory NK Cell to Protect Against COVID-19.利用记忆性自然杀伤细胞预防新冠病毒
Front Pharmacol. 2020 Aug 20;11:1309. doi: 10.3389/fphar.2020.01309. eCollection 2020.
5
Future perspective: biologic agents in patients with severe COVID-19.未来展望:重症 COVID-19 患者的生物制剂
Immunopharmacol Immunotoxicol. 2021 Feb;43(1):1-7. doi: 10.1080/08923973.2020.1818770. Epub 2020 Sep 14.
6
Combating COVID-19 with integrated traditional Chinese and Western medicine in China.中国中西医结合抗击新冠肺炎疫情。
Acta Pharm Sin B. 2020 Jul;10(7):1149-1162. doi: 10.1016/j.apsb.2020.06.009. Epub 2020 Jun 27.
7
Absorbed plant MIR2911 in honeysuckle decoction inhibits SARS-CoV-2 replication and accelerates the negative conversion of infected patients.金银花汤剂中被吸收的植物MIR2911可抑制新型冠状病毒复制并加速感染患者转阴。
Cell Discov. 2020 Aug 5;6(1):54. doi: 10.1038/s41421-020-00197-3. eCollection 2020.
8
COVID-19 pneumonia: CD8 T and NK cells are decreased in number but compensatory increased in cytotoxic potential.COVID-19 肺炎:CD8 T 细胞和 NK 细胞数量减少,但细胞毒性潜能代偿性增加。
Clin Immunol. 2020 Sep;218:108516. doi: 10.1016/j.clim.2020.108516. Epub 2020 Jun 20.
9
Protection against COVID-19 injury by qingfei paidu decoction via anti-viral, anti-inflammatory activity and metabolic programming.清肺排毒汤通过抗病毒、抗炎活性和代谢编程来预防 COVID-19 损伤。
Biomed Pharmacother. 2020 Sep;129:110281. doi: 10.1016/j.biopha.2020.110281. Epub 2020 May 25.
10
Hepatocyte-specific TAK1 deficiency drives RIPK1 kinase-dependent inflammation to promote liver fibrosis and hepatocellular carcinoma.肝实质细胞特异性 TAK1 缺乏导致 RIPK1 激酶依赖性炎症,从而促进肝纤维化和肝细胞癌。
Proc Natl Acad Sci U S A. 2020 Jun 23;117(25):14231-14242. doi: 10.1073/pnas.2005353117. Epub 2020 Jun 8.